Wyden Weighs Substituting Domestic For International Reference Pricing

By John Wilkerson / July 6, 2021 at 3:14 PM
Senate Finance Committee Chair Ron Wyden is considering substituting domestic reference pricing for House Democrats’ international reference pricing scheme in his bill to let Medicare negotiate drug prices, and the Oregon Democrat is considering including a drug appraisal entity that would help government negotiators by assessing what drugs are worth, according to lobbyists who support government negotiation. Wyden’s bill also is expected to include a measure specific to insulin. Wyden’s office declined to discuss whether those measures are under consideration...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.